US Stock MarketDetailed Quotes

BLTE Belite Bio

Watchlist
  • 38.370
  • -1.560-3.91%
Close Mar 28 16:00 ET
1.12BMarket Cap-32243P/E (TTM)

About Belite Bio Company

Belite Bio, Inc. is a biopharmaceutical company engaged in the research and development of drugs. Its focus is on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. It also caters to metabolic diseases such as non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout. The company was founded by Yu-Hsin Lin on March 27, 2018 and is headquartered in San Diego, CA.

Company Profile

SymbolBLTE
Company NameBelite Bio
Listing Date04/29/2022
Issue Price6.00
Founded2018
CEODr. Yu-Hsin Lin
MarketNASDAQ
Employees20
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address12750 High Bluff Drive,Suite 475
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-858-246-6240

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Yu-Hsin Lin
  • Chief Executive Officer and Chairman of the Board
  • --
  • Hao-Yuan Chuang
  • Chief Financial Officer and Director
  • --
  • Nathan L. Mata
  • Chief Scientific Officer
  • --
  • Ching-Chen Chiu
  • Vice President, Clinical Operations
  • --
  • Dr. Wei-Cheng Liaw
  • Vice President, Pharmaceutical Sciences
  • --
  • Wan-Shan Chen
  • Director
  • --
  • Hung-Wei Chen
  • Director
  • --
  • Professor Gary Clark Biddle
  • Independent Director
  • --
  • Dr. John M. Longo
  • Independent Director
  • --
  • Ita Lu
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg